Q: What is Recursion Pharmaceuticals, Inc. Class A Common Stock's WACC?

Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) has a Weighted Average Cost of Capital (WACC) of 12.38%. This is calculated using a Cost of Equity of 12.34% (via CAPM with a beta of 2.29) and a pre-tax Cost of Debt of 23.01%, with an equity weight of 99.64% in the capital structure.

Question 1

What is Recursion Pharmaceuticals, Inc. Class A Common Stock's WACC?

Accepted Answer

Recursion Pharmaceuticals, Inc. Class A Common Stock（RXRX） WACC 解读

Recursion Pharmaceuticals, Inc. Class A Common Stock（RXRX）当前估算的 WACC 为 12.38%。其中股权成本为 12.34%，税前债务成本为 23.01%，股权权重为 99.64%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于相对较高区间，通常意味着资本成本更高、估值对折现率更敏感。

Question 2

Is Recursion Pharmaceuticals, Inc. Class A Common Stock's WACC high or low?

Accepted Answer

Recursion Pharmaceuticals, Inc. Class A Common Stock（RXRX） WACC 解读

Recursion Pharmaceuticals, Inc. Class A Common Stock（RXRX）当前估算的 WACC 为 12.38%。其中股权成本为 12.34%，税前债务成本为 23.01%，股权权重为 99.64%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于相对较高区间，通常意味着资本成本更高、估值对折现率更敏感。

Question 3

How is Recursion Pharmaceuticals, Inc. Class A Common Stock's WACC calculated?

Accepted Answer

Recursion Pharmaceuticals, Inc. Class A Common Stock（RXRX） WACC 解读

Recursion Pharmaceuticals, Inc. Class A Common Stock（RXRX）当前估算的 WACC 为 12.38%。其中股权成本为 12.34%，税前债务成本为 23.01%，股权权重为 99.64%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于相对较高区间，通常意味着资本成本更高、估值对折现率更敏感。

Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) — WACC 分析

WACC 构成

解读

Recursion Pharmaceuticals, Inc. Class A Common Stock（RXRX）WACC：12.38%

WACC计算器

Recursion Pharmaceuticals, Inc. Class A Common Stock（RXRX） WACC 解读

RXRX 公司分析

RXRX DCF 估值

继续做同行对比